PMID- 17397765
OWN - NLM
STAT- MEDLINE
DCOM- 20070622
LR  - 20181201
IS  - 0887-7963 (Print)
IS  - 0887-7963 (Linking)
VI  - 21
IP  - 2
DP  - 2007 Apr
TI  - Jon Van Rood: pioneer at the crossroad of human leukocyte antigens and 
      transplantation.
PG  - 159-63
AB  - Jon Van Rood (born in 1926) has made major contributions to the fields of 
      transfusion medicine as well as organ and stem cell transplantation. His group 
      was the first to start unraveling the complexity of the human leukocyte antigen 
      (HLA) system through collaborative studies that used panels of sera and leukocyte 
      samples. Furthermore, using HLA typing, he introduced the first HLA-matched 
      platelet transfusions and developed routine leukocyte depletion as a means to 
      prevent HLA alloimmunization. Van Rood has also been active in the fields of 
      kidney transplantation (Eurotransplant) and stem cell transplantation 
      (Europdonor). He combined scientific laboratory research with application to 
      clinical medicine. He retired from his university position in 1991 but remains 
      active in the field.
FAU - Jansen, Jan
AU  - Jansen J
AD  - Indiana Blood and Marrow Transplantation, IN 46205, USA. jjansen@ibmtindy.com
LA  - eng
PT  - Biography
PT  - Historical Article
PT  - Journal Article
PT  - Portrait
PL  - United States
TA  - Transfus Med Rev
JT  - Transfusion medicine reviews
JID - 8709027
RN  - 0 (HLA Antigens)
SB  - IM
MH  - *HLA Antigens/history/immunology
MH  - *Histocompatibility Testing/history
MH  - History, 20th Century
MH  - History, 21st Century
MH  - *Kidney Transplantation/history/methods
MH  - *Platelet Transfusion/history
MH  - *Stem Cell Transplantation/history/methods
PS  - Van Rood J
FPS - Van Rood, Jon
EDAT- 2007/04/03 09:00
MHDA- 2007/06/23 09:00
CRDT- 2007/04/03 09:00
PHST- 2007/04/03 09:00 [pubmed]
PHST- 2007/06/23 09:00 [medline]
PHST- 2007/04/03 09:00 [entrez]
AID - S0887-7963(06)00097-6 [pii]
AID - 10.1016/j.tmrv.2006.11.006 [doi]
PST - ppublish
SO  - Transfus Med Rev. 2007 Apr;21(2):159-63. doi: 10.1016/j.tmrv.2006.11.006.